About SONIRE Therapeutics
SONIRE Therapeutics is a company based in Tokyo (Japan) founded in 2020. SONIRE Therapeutics has raised $16.97 million across 3 funding rounds from investors including JA Mitsui Leasing, Carbon Ventures and Resona Capital. SONIRE Therapeutics operates in a competitive market with competitors including Insightec, HistoSonics, Profound Medical, Theraclion and Carthera, among others.
- Headquarter Tokyo, Japan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.97 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
JA Mitsui Leasing
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SONIRE Therapeutics
SONIRE Therapeutics has successfully raised a total of $16.97M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SONIRE Therapeutics
SONIRE Therapeutics has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include JA Mitsui Leasing, Carbon Ventures and Resona Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Carbon Ventures is focused on investing in sustainable infrastructure technologies.
|
Locked | Locked | Locked | |
|
Venture capital services are provided to support startups and innovation.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in biotech, adtech sectors
|
Locked | Locked | Locked |
Investor details for SONIRE Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SONIRE Therapeutics
Investment portfolio details for SONIRE Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SONIRE Therapeutics
Detailed financials for SONIRE Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sonire Therapeutics Comparisons
Peer comparison for SONIRE Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SONIRE Therapeutics
SONIRE Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, HistoSonics, Profound Medical, Theraclion and Carthera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
|
|
| Locked | Locked | Locked |
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
|
|
| Locked | Locked | Locked |
Image-guided prostate ablation systems for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Provider of non-invasive robotic ultrasound therapy devices
|
|
| Locked | Locked | Locked |
Ultrasound-based medical devices for brain tumor treatment are developed.
|
Detailed competitors of SONIRE Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sonire Therapeutics
Complete news archive for SONIRE Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SONIRE Therapeutics
SONIRE Therapeutics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
SONIRE Therapeutics is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Tohru Satoh is the current CEO of SONIRE Therapeutics.
SONIRE Therapeutics is a funded company, having raised a total of $16.97M across 3 funding rounds to date.
SONIRE Therapeutics was founded in 2020 in Tokyo, Japan, within the medical device sector. High-intensity focused ultrasound treatment systems are developed by the company, utilizing cavitation bubbles to improve efficacy and enable visualization through heating mechanisms. Pancreatic cancer is addressed via clinical trials that employ high-energy ultrasound waves to target and destroy cancer cells in specific areas. Operations focus on advancing non-invasive therapeutic technologies for oncology applications.
SONIRE Therapeutics's top competitors include Insightec, HistoSonics and Profound Medical.
SONIRE Therapeutics has 13 investors. Key investors include JA Mitsui Leasing, Carbon Ventures, Resona Capital, Daiwa Corporate Investment, and Nissay Capital.